Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - terlipressin, quantity: 1.7 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

Australia - English - Department of Health (Therapeutic Goods Administration)

interpharma pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; glacial acetic acid; sodium hydroxide; hydrochloric acid; water for injections - terlipressin ever pharma solution for injection is indicated for the: - treatment of bleeding oesophageal varices; - treatment of patients with hepatorenal syndrome (hrs) type 1 who are actively being considered for liver transplant.

Ireland - English - HPRA (Health Products Regulatory Authority)

ever valinject gmbh - terlipressin acetate - solution for injection - 0.2 milligram(s)/millilitre - terlipressin

Israel - English - Ministry of Health

propharm ltd - terlipressin as acetate - solution for injection - terlipressin as acetate 0.1 mg/ml - terlipressin - bleeding oesophageal varices. treatment of type i hepatorenal syndrome

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - terlipressin acetate - solution for injection - 120microgram/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - terlipressin, quantity: 0.85 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium acetate trihydrate; acetic acid - glypressin is indicated for the:,?treatment of bleeding oesophageal varices (bov);,?treatment of patients with type 1 hepatorenal syndrome (hrs) who are actively beingconsidered for liver transplant.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - terlipressin acetate 0.2 mg/ml equivalent to terlipressin 0.17mg/ml;   - solution for injection - 1 mg/5ml - active: terlipressin acetate 0.2 mg/ml equivalent to terlipressin 0.17mg/ml   excipient: glacial acetic acid hydrochloric acid sodium chloride sodium hydroxide water for injection - indicated for: - the treatment of bleeding oesophageal varices (bov); and - type 1 hepatorenal syndrome, characterised by spontaneous acute renal insufficiency, in patients suffering from severe cirrhosis with ascites.

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - terlipressin acetate 0.2 mg/ml equivalent to terlipressin 0.17mg/ml;   - solution for injection - 2 mg/10ml - active: terlipressin acetate 0.2 mg/ml equivalent to terlipressin 0.17mg/ml   excipient: glacial acetic acid hydrochloric acid sodium chloride sodium hydroxide water for injection - indicated for: - the treatment of bleeding oesophageal varices (bov); and - type 1 hepatorenal syndrome, characterised by spontaneous acute renal insufficiency, in patients suffering from severe cirrhosis with ascites.

Israel - English - Ministry of Health

pharmalogic ltd - terlipressin acetate - solution for injection - terlipressin acetate 0.2 mg/ml - terlipressin - bleeding oesophageal varices. treatment of type i hepatorenal syndrome.

Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - terlipressin -